RJ BLACKLEY ADATC
1. Target Overview & Investment Thesis
RJ BLACKLEY ADATC is a 60-bed under-performing / distressed in GRANVILLE, NC with $13.8M in net patient revenue and a -39.6% operating margin. The hospital serves a payer mix of 2.4% Medicare, 30.6% Medicaid, and 67.0% commercial.
Thesis: Turnaround. Our ML models identify $1.0M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -39.6% to -32.2% (+737bps).
| Net Revenue HCRIS | $13.8M |
| Current EBITDA COMPUTED | $-5.5M |
| Operating Margin COMPUTED | -39.6% |
| Occupancy HCRIS | 16.1% |
| Revenue / Bed COMPUTED | $231K |
| Net-to-Gross HCRIS | 100.0% |
| Distress Probability ML | 69.5% |
2. Market Context & Competitive Position
NC has 129 Medicare-certified hospitals with a median operating margin of -2.0%. The target's margin of -39.6% places it below the state median. Among 50 size-comparable peers (30-120 beds), the median margin is -2.4%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (30-120), prioritizing same-state peers. 50 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| RJ BLACKLEY ADATC (Target) | NC | 60 | $13.8M | -39.6% |
| ATRIUM HEALTH UNIVERSITY CITY | NC | 104 | $286.9M | 28.6% |
| ADVENTHEALTH HENDERSONVILLE | NC | 73 | $227.1M | -4.1% |
| THOMASVILLE MEDICAL CENTER | NC | 73 | $220.3M | -14.3% |
| SCOTLAND MEMORIAL HOSPITAL | NC | 104 | $198.0M | -2.8% |
| WATAUGA MEDICAL CENTER | NC | 95 | $187.3M | 2.4% |
| CARTERET COUNTY GENERAL HOSPIT | NC | 99 | $187.2M | 6.4% |
| ATRIUM HEALTH LINCOLN | NC | 101 | $144.6M | 22.2% |
| BRUNSWICK COMMUNITY HOSPITAL | NC | 65 | $143.2M | 12.9% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.0M (737bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $291K | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $277K | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $275K | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $168K | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $10K | +7bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-5.5M |
| + RCM Uplift | +$1.0M |
| Pro Forma EBITDA | $-4.5M |
| Current Margin | -39.6% |
| Pro Forma Margin | -32.2% |
| WC Released (1x) | $531K |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-8.4M | $-25.9M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-8.4M | $-31.3M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-7.6M | $-30.6M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-7.6M | $-35.7M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-9.3M | $-28.3M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-9.3M | $-34.1M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| Medium | Elevated Medicaid exposure (30.6%) | Medicaid reimburses below cost in most states. Mitigant: denial reduction lever has highest impact on Medicaid claims |
| Medium | Low occupancy | At 16.1%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case |
| High | Elevated distress probability | Model estimates 69.5% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 50 hospitals with 30-120 beds
- Same-state prioritization (n=51)
- Comp margins: P25=-11.1% / P50=-2.4% / P75=10.0%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.